Home Tags Pivotal Phase III Trial

Tag: Pivotal Phase III Trial

Collaboration to Evaluate Combination of Nivolumab + Brentuximab Vedotin in Pivotal...

Bristol-Myers Squibb and Seattle Genetics have expanded their collaboration to evaluate the combination of the immunotherapy Nivolumab (Opdivo®) and the antibody-drug conjugate or ADC...